APO Research
Talk to an analyst

APO RESEARCH · REPORT

Budesonide (BUD)

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Budesonide (BUD) Industry Growth and Trends Forecast to 2032

20 December 2025106 pages

Choose your research edition.

Industry ResearchBudesonide (BUD) Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Budesonide (BUD) Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal Budesonide (BUD) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Budesonide (BUD) Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Budesonide (BUD) Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Budesonide (BUD) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Budesonide (BUD) is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Budesonide (BUD) is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Budesonide (BUD) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Budesonide (BUD) include Chiesi Farmaceutici, Cipla, Cosmo Pharmaceuticals, Dr. Falk Pharma, Lunan Better Pharmaceutical, Orion, Shanghai Sine Promod Pharmaceutical, Synmosa Biopharma and AstraZeneca, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Budesonide (BUD) market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Budesonide (BUD) market size, estimates, and forecasts are presented in terms of sales volume (k tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Budesonide (BUD) market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Budesonide (BUD).

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Budesonide (BUD) market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Budesonide (BUD) Market by Company

Chiesi Farmaceutici

Cipla

Cosmo Pharmaceuticals

Dr. Falk Pharma

Lunan Better Pharmaceutical

Orion

Shanghai Sine Promod Pharmaceutical

Synmosa Biopharma

AstraZeneca

Mylan

Sandoz

Teva

Budesonide (BUD) Segment by Type

Pill

Inhaler

Nasal Spray

Budesonide (BUD) Segment by Application

Nose Disease Treatment

Respiratory Disease Treatment

Inflammatory Bowel Disease Treatment

Budesonide (BUD) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Budesonide (BUD) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Budesonide (BUD) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Budesonide (BUD).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Budesonide (BUD) manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Budesonide (BUD) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Pill Table 2. Major Company of Inhaler Table 3. Major Company of Nasal Spray Table 4. Global Budesonide (BUD) Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Budesonide (BUD) Sales by Type (2021-2026) & (k tons) Table 6. Global Budesonide (BUD) Sales Market Share in Volume by Type (2021-2026) Table 7. Global Budesonide (BUD) Sales by Type (2021-2026) & (US$ Million) Table 8. Global Budesonide (BUD) Sales Market Share in Value by Type (2021-2026) Table 9. Global Budesonide (BUD) Price by Type (2021-2026) & (US$/ton) Table 10. Global Budesonide (BUD) Sales by Type (2027-2032) & (k tons) Table 11. Global Budesonide (BUD) Sales Market Share in Volume by Type (2027-2032) Table 12. Global Budesonide (BUD) Sales by Type (2027-2032) & (US$ Million) Table 13. Global Budesonide (BUD) Sales Market Share in Value by Type (2027-2032) Table 14. Global Budesonide (BUD) Price by Type (2027-2032) & (US$/ton) Table 15. North America Budesonide (BUD) Sales by Type (2021-2026) & (k tons) Table 16. North America Budesonide (BUD) Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Budesonide (BUD) Sales by Type (2021-2026) & (k tons) Table 18. Europe Budesonide (BUD) Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Budesonide (BUD) Sales by Type (2021-2026) & (k tons) Table 20. Asia-Pacific Budesonide (BUD) Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Budesonide (BUD) Sales by Type (2021-2026) & (k tons) Table 22. Latin America Budesonide (BUD) Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Budesonide (BUD) Sales by Type (2021-2026) & (k tons) Table 24. Middle East and Africa Budesonide (BUD) Sales by Type (2021-2026) & (US$ Million) Table 25. Budesonide (BUD) Industry Trends Table 26. Budesonide (BUD) Industry Drivers Table 27. Budesonide (BUD) Industry Opportunities and Challenges Table 28. Budesonide (BUD) Industry Restraints Table 29. Global Budesonide (BUD) Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Budesonide (BUD) Revenue Market Share by Company (2021-2026) Table 31. Global Budesonide (BUD) Sales by Company (2021-2026) & (k tons) Table 32. Global Budesonide (BUD) Sales Share by Company (2021-2026) Table 33. Global Budesonide (BUD) Market Price by Company (2021-2026) & (US$/ton) Table 34. Global Budesonide (BUD) Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Budesonide (BUD) Major Company Production Sites and Headquarters Table 36. Global Budesonide (BUD) Company, Product Type & Application Table 37. Global Budesonide (BUD) Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Budesonide (BUD) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Budesonide (BUD) Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Budesonide (BUD) Sales by Region (2021-2026) & (k tons) Table 42. Global Budesonide (BUD) Sales Market Share in Volume by Region (2021-2026) Table 43. Global Budesonide (BUD) Sales by Region (2021-2026) & (US$ Million) Table 44. Global Budesonide (BUD) Sales Market Share in Value by Region (2021-2026) Table 45. Global Budesonide (BUD) Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 46. Global Budesonide (BUD) Sales by Region (2027-2032) & (k tons) Table 47. Global Budesonide (BUD) Sales Market Share in Volume by Region (2027-2032) Table 48. Global Budesonide (BUD) Sales by Region (2027-2032) & (US$ Million) Table 49. Global Budesonide (BUD) Sales Market Share in Value by Region (2027-2032) Table 50. Global Budesonide (BUD) Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2027-2032) Table 51. Global Budesonide (BUD) Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Budesonide (BUD) Sales by Application (2021-2026) & (k tons) Table 53. Global Budesonide (BUD) Sales Market Share in Volume by Application (2021-2026) Table 54. Global Budesonide (BUD) Sales by Application (2021-2026) & (US$ Million) Table 55. Global Budesonide (BUD) Sales Market Share in Value by Application (2021-2026) Table 56. Global Budesonide (BUD) Price by Application (2021-2026) & (US$/ton) Table 57. Global Budesonide (BUD) Sales by Application (2027-2032) & (k tons) Table 58. Global Budesonide (BUD) Sales Market Share in Volume by Application (2027-2032) Table 59. Global Budesonide (BUD) Sales by Application (2027-2032) & (US$ Million) Table 60. Global Budesonide (BUD) Sales Market Share in Value by Application (2027-2032) Table 61. Global Budesonide (BUD) Price by Application (2027-2032) & (US$/ton) Table 62. North America Budesonide (BUD) Sales by Application (2021-2026) & (k tons) Table 63. North America Budesonide (BUD) Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Budesonide (BUD) Sales by Application (2021-2026) & (k tons) Table 65. Europe Budesonide (BUD) Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Budesonide (BUD) Sales by Application (2021-2026) & (k tons) Table 67. Asia-Pacific Budesonide (BUD) Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Budesonide (BUD) Sales by Application (2021-2026) & (k tons) Table 69. Latin America Budesonide (BUD) Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Budesonide (BUD) Sales by Application (2021-2026) & (k tons) Table 71. Middle East and Africa Budesonide (BUD) Sales by Application (2021-2026) & (US$ Million) Table 72. Chiesi Farmaceutici Company Information Table 73. Chiesi Farmaceutici Business Overview Table 74. Chiesi Farmaceutici Budesonide (BUD) Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 75. Chiesi Farmaceutici Budesonide (BUD) Product Portfolio Table 76. Chiesi Farmaceutici Recent Development Table 77. Cipla Company Information Table 78. Cipla Business Overview Table 79. Cipla Budesonide (BUD) Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 80. Cipla Budesonide (BUD) Product Portfolio Table 81. Cipla Recent Development Table 82. Cosmo Pharmaceuticals Company Information Table 83. Cosmo Pharmaceuticals Business Overview Table 84. Cosmo Pharmaceuticals Budesonide (BUD) Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 85. Cosmo Pharmaceuticals Budesonide (BUD) Product Portfolio Table 86. Cosmo Pharmaceuticals Recent Development Table 87. Dr. Falk Pharma Company Information Table 88. Dr. Falk Pharma Business Overview Table 89. Dr. Falk Pharma Budesonide (BUD) Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 90. Dr. Falk Pharma Budesonide (BUD) Product Portfolio Table 91. Dr. Falk Pharma Recent Development Table 92. Lunan Better Pharmaceutical Company Information Table 93. Lunan Better Pharmaceutical Business Overview Table 94. Lunan Better Pharmaceutical Budesonide (BUD) Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 95. Lunan Better Pharmaceutical Budesonide (BUD) Product Portfolio Table 96. Lunan Better Pharmaceutical Recent Development Table 97. Orion Company Information Table 98. Orion Business Overview Table 99. Orion Budesonide (BUD) Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 100. Orion Budesonide (BUD) Product Portfolio Table 101. Orion Recent Development Table 102. Shanghai Sine Promod Pharmaceutical Company Information Table 103. Shanghai Sine Promod Pharmaceutical Business Overview Table 104. Shanghai Sine Promod Pharmaceutical Budesonide (BUD) Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 105. Shanghai Sine Promod Pharmaceutical Budesonide (BUD) Product Portfolio Table 106. Shanghai Sine Promod Pharmaceutical Recent Development Table 107. Synmosa Biopharma Company Information Table 108. Synmosa Biopharma Business Overview Table 109. Synmosa Biopharma Budesonide (BUD) Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 110. Synmosa Biopharma Budesonide (BUD) Product Portfolio Table 111. Synmosa Biopharma Recent Development Table 112. AstraZeneca Company Information Table 113. AstraZeneca Business Overview Table 114. AstraZeneca Budesonide (BUD) Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 115. AstraZeneca Budesonide (BUD) Product Portfolio Table 116. AstraZeneca Recent Development Table 117. Mylan Company Information Table 118. Mylan Business Overview Table 119. Mylan Budesonide (BUD) Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 120. Mylan Budesonide (BUD) Product Portfolio Table 121. Mylan Recent Development Table 122. Sandoz Company Information Table 123. Sandoz Business Overview Table 124. Sandoz Budesonide (BUD) Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 125. Sandoz Budesonide (BUD) Product Portfolio Table 126. Sandoz Recent Development Table 127. Teva Company Information Table 128. Teva Business Overview Table 129. Teva Budesonide (BUD) Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 130. Teva Budesonide (BUD) Product Portfolio Table 131. Teva Recent Development Table 132. North America Budesonide (BUD) Market Size Growth Rate (CAGR) by Country (k tons): 2021 VS 2025 VS 2032 Table 133. North America Budesonide (BUD) Sales by Country (2021-2026) & (k tons) Table 134. North America Budesonide (BUD) Sales Market Share by Country (2021-2026) Table 135. North America Budesonide (BUD) Sales Forecast by Country (2027-2032) & (k tons) Table 136. North America Budesonide (BUD) Sales Market Share Forecast by Country (2027-2032) Table 137. North America Budesonide (BUD) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 138. North America Budesonide (BUD) Market Size by Country (2021-2026) & (US$ Million) Table 139. North America Budesonide (BUD) Market Share by Country (2021-2026) Table 140. North America Budesonide (BUD) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 141. North America Budesonide (BUD) Market Share Forecast by Country (2027-2032) Table 142. Europe Budesonide (BUD) Market Size Growth Rate (CAGR) by Country (k tons): 2021 VS 2025 VS 2032 Table 143. Europe Budesonide (BUD) Sales by Country (2021-2026) & (k tons) Table 144. Europe Budesonide (BUD) Sales Market Share by Country (2021-2026) Table 145. Europe Budesonide (BUD) Sales Forecast by Country (2027-2032) & (k tons) Table 146. Europe Budesonide (BUD) Sales Market Share Forecast by Country (2027-2032) Table 147. Europe Budesonide (BUD) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. Europe Budesonide (BUD) Market Size by Country (2021-2026) & (US$ Million) Table 149. Europe Budesonide (BUD) Market Share by Country (2021-2026) Table 150. Europe Budesonide (BUD) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. Europe Budesonide (BUD) Market Share Forecast by Country (2027-2032) Table 152. Asia-Pacific Budesonide (BUD) Market Size Growth Rate (CAGR) by Country (k tons): 2021 VS 2025 VS 2032 Table 153. Asia-Pacific Budesonide (BUD) Sales by Country (2021-2026) & (k tons) Table 154. Asia-Pacific Budesonide (BUD) Sales Market Share by Country (2021-2026) Table 155. Asia-Pacific Budesonide (BUD) Sales Forecast by Country (2027-2032) & (k tons) Table 156. Asia-Pacific Budesonide (BUD) Sales Market Share Forecast by Country (2027-2032) Table 157. Asia-Pacific Budesonide (BUD) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 158. Asia-Pacific Budesonide (BUD) Market Size by Country (2021-2026) & (US$ Million) Table 159. Asia-Pacific Budesonide (BUD) Market Share by Country (2021-2026) Table 160. Asia-Pacific Budesonide (BUD) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 161. Asia-Pacific Budesonide (BUD) Market Share Forecast by Country (2027-2032) Table 162. Latin America Budesonide (BUD) Market Size Growth Rate (CAGR) by Country (k tons): 2021 VS 2025 VS 2032 Table 163. Latin America Budesonide (BUD) Sales by Country (2021-2026) & (k tons) Table 164. Latin America Budesonide (BUD) Sales Market Share by Country (2021-2026) Table 165. Latin America Budesonide (BUD) Sales Forecast by Country (2027-2032) & (k tons) Table 166. Latin America Budesonide (BUD) Sales Market Share Forecast by Country (2027-2032) Table 167. Latin America Budesonide (BUD) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 168. Latin America Budesonide (BUD) Market Size by Country (2021-2026) & (US$ Million) Table 169. Latin America Budesonide (BUD) Market Share by Country (2021-2026) Table 170. Latin America Budesonide (BUD) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 171. Latin America Budesonide (BUD) Market Share Forecast by Country (2027-2032) Table 172. Middle East and Africa Budesonide (BUD) Market Size Growth Rate (CAGR) by Country (k tons): 2021 VS 2025 VS 2032 Table 173. Middle East and Africa Budesonide (BUD) Sales by Country (2021-2026) & (k tons) Table 174. Middle East and Africa Budesonide (BUD) Sales Market Share by Country (2021-2026) Table 175. Middle East and Africa Budesonide (BUD) Sales Forecast by Country (2027-2032) & (k tons) Table 176. Middle East and Africa Budesonide (BUD) Sales Market Share Forecast by Country (2027-2032) Table 177. Middle East and Africa Budesonide (BUD) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 178. Middle East and Africa Budesonide (BUD) Market Size by Country (2021-2026) & (US$ Million) Table 179. Middle East and Africa Budesonide (BUD) Market Share by Country (2021-2026) Table 180. Middle East and Africa Budesonide (BUD) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 181. Middle East and Africa Budesonide (BUD) Market Share Forecast by Country (2027-2032) Table 182. Key Raw Materials Table 183. Raw Materials Key Suppliers Table 184. Budesonide (BUD) Distributors List Table 185. Budesonide (BUD) Customers List Table 186. Research Programs/Design for This Report Table 187. Authors List of This Report Table 188. Secondary Sources Table 189. Primary Sources List of Figures Figure 1. Budesonide (BUD) Image Figure 2. Global Budesonide (BUD) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Budesonide (BUD) Market Size (2021-2032) & (US$ Million) Figure 4. Global Budesonide (BUD) Sales (2021-2032) & (k tons) Figure 5. Pill Image Figure 6. Global Pill Sales YoY Growth (2021-2032) & (k tons) Figure 7. Inhaler Image Figure 8. Global Inhaler Sales YoY Growth (2021-2032) & (k tons) Figure 9. Nasal Spray Image Figure 10. Global Nasal Spray Sales YoY Growth (2021-2032) & (k tons) Figure 11. Global Budesonide (BUD) Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Budesonide (BUD) Market Share by Type 2025 VS 2032 Figure 13. North America Budesonide (BUD) Sales Market Share in Volume by Type in 2025 Figure 14. North America Budesonide (BUD) Sales Market Share in Value by Type in 2025 Figure 15. Europe Budesonide (BUD) Sales Market Share in Volume by Type in 2025 Figure 16. Europe Budesonide (BUD) Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Budesonide (BUD) Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Budesonide (BUD) Sales Market Share in Value by Type in 2025 Figure 19. Latin America Budesonide (BUD) Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Budesonide (BUD) Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Budesonide (BUD) Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Budesonide (BUD) Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Budesonide (BUD) Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Nose Disease Treatment Image Figure 26. Global Nose Disease Treatment Sales YoY Growth (2021-2032) & (k tons) Figure 27. Respiratory Disease Treatment Image Figure 28. Global Respiratory Disease Treatment Sales YoY Growth (2021-2032) & (k tons) Figure 29. Inflammatory Bowel Disease Treatment Image Figure 30. Global Inflammatory Bowel Disease Treatment Sales YoY Growth (2021-2032) & (k tons) Figure 31. Global Budesonide (BUD) Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Budesonide (BUD) Market Share by Application 2025 VS 2032 Figure 33. North America Budesonide (BUD) Sales Market Share in Volume by Application in 2025 Figure 34. North America Budesonide (BUD) Sales Market Share in Value by Application in 2025 Figure 35. Europe Budesonide (BUD) Sales Market Share in Volume by Application in 2025 Figure 36. Europe Budesonide (BUD) Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Budesonide (BUD) Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Budesonide (BUD) Sales Market Share in Value by Application in 2025 Figure 39. Latin America Budesonide (BUD) Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Budesonide (BUD) Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Budesonide (BUD) Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Budesonide (BUD) Sales Market Share in Value by Application in 2025 Figure 43. North America Budesonide (BUD) Sales by Country: 2021 VS 2025 VS 2032 (k tons) Figure 44. North America Budesonide (BUD) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Budesonide (BUD) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Budesonide (BUD) Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Budesonide (BUD) Sales by Country: 2021 VS 2025 VS 2032 (k tons) Figure 48. Europe Budesonide (BUD) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Budesonide (BUD) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Budesonide (BUD) Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Budesonide (BUD) Sales by Country: 2021 VS 2025 VS 2032 (k tons) Figure 52. Asia-Pacific Budesonide (BUD) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Budesonide (BUD) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Budesonide (BUD) Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Budesonide (BUD) Sales by Country: 2021 VS 2025 VS 2032 (k tons) Figure 56. Latin America Budesonide (BUD) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Budesonide (BUD) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Budesonide (BUD) Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Budesonide (BUD) Sales by Country: 2021 VS 2025 VS 2032 (k tons) Figure 60. Middle East and Africa Budesonide (BUD) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Budesonide (BUD) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Budesonide (BUD) Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Budesonide (BUD) Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Budesonide (BUD) Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Pill
  • Inhaler
  • Nasal Spray
Applications
  • Nose Disease Treatment
  • Respiratory Disease Treatment
  • Inflammatory Bowel Disease Treatment
Companies covered
  • Chiesi Farmaceutici
  • Cipla
  • Cosmo Pharmaceuticals
  • Dr. Falk Pharma
  • Lunan Better Pharmaceutical
  • Orion
  • Shanghai Sine Promod Pharmaceutical
  • Synmosa Biopharma
  • AstraZeneca
  • Mylan
  • Sandoz
  • Teva

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Budesonide (BUD) Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Budesonide (BUD) Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Budesonide (BUD) Market by Type
  6. 1.3.1 Pill
  7. 1.3.2 Inhaler
  8. 1.3.3 Nasal Spray
  9. 1.4 Global Budesonide (BUD) Market Size by Type
  10. 1.4.1 Global Budesonide (BUD) Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Budesonide (BUD) Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Budesonide (BUD) Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Budesonide (BUD) Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Budesonide (BUD) Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Budesonide (BUD) Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Budesonide (BUD) Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Budesonide (BUD) Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Budesonide (BUD) Industry Trends
  2. 2.2 Budesonide (BUD) Industry Drivers
  3. 2.3 Budesonide (BUD) Industry Opportunities and Challenges
  4. 2.4 Budesonide (BUD) Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Budesonide (BUD) Revenue (2021-2026)
  2. 3.2 Global Top Players by Budesonide (BUD) Sales (2021-2026)
  3. 3.3 Global Top Players by Budesonide (BUD) Price (2021-2026)
  4. 3.4 Global Budesonide (BUD) Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Budesonide (BUD) Major Company Production Sites & Headquarters
  6. 3.6 Global Budesonide (BUD) Company, Product Type & Application
  7. 3.7 Global Budesonide (BUD) Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Budesonide (BUD) Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Budesonide (BUD) Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Budesonide (BUD) Tier 1, Tier 2, and Tier 3
4 Budesonide (BUD) Regional Status and Outlook
  1. 4.1 Global Budesonide (BUD) Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Budesonide (BUD) Historic Market Size by Region
  3. 4.2.1 Global Budesonide (BUD) Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Budesonide (BUD) Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Budesonide (BUD) Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Budesonide (BUD) Forecasted Market Size by Region
  7. 4.3.1 Global Budesonide (BUD) Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Budesonide (BUD) Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Budesonide (BUD) Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Budesonide (BUD) by Application
  1. 5.1 Budesonide (BUD) Market by Application
  2. 5.1.1 Nose Disease Treatment
  3. 5.1.2 Respiratory Disease Treatment
  4. 5.1.3 Inflammatory Bowel Disease Treatment
  5. 5.2 Global Budesonide (BUD) Market Size by Application
  6. 5.2.1 Global Budesonide (BUD) Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Budesonide (BUD) Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Budesonide (BUD) Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Budesonide (BUD) Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Budesonide (BUD) Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Budesonide (BUD) Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Budesonide (BUD) Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Budesonide (BUD) Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Chiesi Farmaceutici
  2. 6.1.1 Chiesi Farmaceutici Company Information
  3. 6.1.2 Chiesi Farmaceutici Business Overview
  4. 6.1.3 Chiesi Farmaceutici Budesonide (BUD) Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Chiesi Farmaceutici Budesonide (BUD) Product Portfolio
  6. 6.1.5 Chiesi Farmaceutici Recent Developments
  7. 6.2 Cipla
  8. 6.2.1 Cipla Company Information
  9. 6.2.2 Cipla Business Overview
  10. 6.2.3 Cipla Budesonide (BUD) Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Cipla Budesonide (BUD) Product Portfolio
  12. 6.2.5 Cipla Recent Developments
  13. 6.3 Cosmo Pharmaceuticals
  14. 6.3.1 Cosmo Pharmaceuticals Company Information
  15. 6.3.2 Cosmo Pharmaceuticals Business Overview
  16. 6.3.3 Cosmo Pharmaceuticals Budesonide (BUD) Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Cosmo Pharmaceuticals Budesonide (BUD) Product Portfolio
  18. 6.3.5 Cosmo Pharmaceuticals Recent Developments
  19. 6.4 Dr. Falk Pharma
  20. 6.4.1 Dr. Falk Pharma Company Information
  21. 6.4.2 Dr. Falk Pharma Business Overview
  22. 6.4.3 Dr. Falk Pharma Budesonide (BUD) Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Dr. Falk Pharma Budesonide (BUD) Product Portfolio
  24. 6.4.5 Dr. Falk Pharma Recent Developments
  25. 6.5 Lunan Better Pharmaceutical
  26. 6.5.1 Lunan Better Pharmaceutical Company Information
  27. 6.5.2 Lunan Better Pharmaceutical Business Overview
  28. 6.5.3 Lunan Better Pharmaceutical Budesonide (BUD) Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Lunan Better Pharmaceutical Budesonide (BUD) Product Portfolio
  30. 6.5.5 Lunan Better Pharmaceutical Recent Developments
  31. 6.6 Orion
  32. 6.6.1 Orion Company Information
  33. 6.6.2 Orion Business Overview
  34. 6.6.3 Orion Budesonide (BUD) Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Orion Budesonide (BUD) Product Portfolio
  36. 6.6.5 Orion Recent Developments
  37. 6.7 Shanghai Sine Promod Pharmaceutical
  38. 6.7.1 Shanghai Sine Promod Pharmaceutical Company Information
  39. 6.7.2 Shanghai Sine Promod Pharmaceutical Business Overview
  40. 6.7.3 Shanghai Sine Promod Pharmaceutical Budesonide (BUD) Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Shanghai Sine Promod Pharmaceutical Budesonide (BUD) Product Portfolio
  42. 6.7.5 Shanghai Sine Promod Pharmaceutical Recent Developments
  43. 6.8 Synmosa Biopharma
  44. 6.8.1 Synmosa Biopharma Company Information
  45. 6.8.2 Synmosa Biopharma Business Overview
  46. 6.8.3 Synmosa Biopharma Budesonide (BUD) Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Synmosa Biopharma Budesonide (BUD) Product Portfolio
  48. 6.8.5 Synmosa Biopharma Recent Developments
  49. 6.9 AstraZeneca
  50. 6.9.1 AstraZeneca Company Information
  51. 6.9.2 AstraZeneca Business Overview
  52. 6.9.3 AstraZeneca Budesonide (BUD) Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 AstraZeneca Budesonide (BUD) Product Portfolio
  54. 6.9.5 AstraZeneca Recent Developments
  55. 6.10 Mylan
  56. 6.10.1 Mylan Company Information
  57. 6.10.2 Mylan Business Overview
  58. 6.10.3 Mylan Budesonide (BUD) Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Mylan Budesonide (BUD) Product Portfolio
  60. 6.10.5 Mylan Recent Developments
  61. 6.11 Sandoz
  62. 6.11.1 Sandoz Company Information
  63. 6.11.2 Sandoz Business Overview
  64. 6.11.3 Sandoz Budesonide (BUD) Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Sandoz Budesonide (BUD) Product Portfolio
  66. 6.11.5 Sandoz Recent Developments
  67. 6.12 Teva
  68. 6.12.1 Teva Company Information
  69. 6.12.2 Teva Business Overview
  70. 6.12.3 Teva Budesonide (BUD) Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Teva Budesonide (BUD) Product Portfolio
  72. 6.12.5 Teva Recent Developments
7 North America by Country
  1. 7.1 North America Budesonide (BUD) Sales by Country
  2. 7.1.1 North America Budesonide (BUD) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Budesonide (BUD) Sales by Country (2021-2026)
  4. 7.1.3 North America Budesonide (BUD) Sales Forecast by Country (2027-2032)
  5. 7.2 North America Budesonide (BUD) Market Size by Country
  6. 7.2.1 North America Budesonide (BUD) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Budesonide (BUD) Market Size by Country (2021-2026)
  8. 7.2.3 North America Budesonide (BUD) Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Budesonide (BUD) Sales by Country
  2. 8.1.1 Europe Budesonide (BUD) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Budesonide (BUD) Sales by Country (2021-2026)
  4. 8.1.3 Europe Budesonide (BUD) Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Budesonide (BUD) Market Size by Country
  6. 8.2.1 Europe Budesonide (BUD) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Budesonide (BUD) Market Size by Country (2021-2026)
  8. 8.2.3 Europe Budesonide (BUD) Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Budesonide (BUD) Sales by Country
  2. 9.1.1 Asia-Pacific Budesonide (BUD) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Budesonide (BUD) Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Budesonide (BUD) Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Budesonide (BUD) Market Size by Country
  6. 9.2.1 Asia-Pacific Budesonide (BUD) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Budesonide (BUD) Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Budesonide (BUD) Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Budesonide (BUD) Sales by Country
  2. 10.1.1 South America Budesonide (BUD) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Budesonide (BUD) Sales by Country (2021-2026)
  4. 10.1.3 South America Budesonide (BUD) Sales Forecast by Country (2027-2032)
  5. 10.2 South America Budesonide (BUD) Market Size by Country
  6. 10.2.1 South America Budesonide (BUD) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Budesonide (BUD) Market Size by Country (2021-2026)
  8. 10.2.3 South America Budesonide (BUD) Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Budesonide (BUD) Sales by Country
  2. 11.1.1 Middle East and Africa Budesonide (BUD) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Budesonide (BUD) Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Budesonide (BUD) Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Budesonide (BUD) Market Size by Country
  6. 11.2.1 Middle East and Africa Budesonide (BUD) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Budesonide (BUD) Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Budesonide (BUD) Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Budesonide (BUD) Value Chain Analysis
  2. 12.1.1 Budesonide (BUD) Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Budesonide (BUD) Production Mode & Process
  7. 12.2 Budesonide (BUD) Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Budesonide (BUD) Distributors
  10. 12.2.3 Budesonide (BUD) Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst